'Anti-vax' woman died after refusing chemotherapy
Paloma Shemirani, who had declined chemotherapy for non-Hodgkin lymphoma, suffered a fatal heart attack caused by her tumour at the Royal Sussex County Hospital (RSCH) on 24 July last year.
The 23-year-old's mother Kay (Kate) Shemirani, who shared Covid conspiracy theories on social media, has blamed doctors' interventions for her daughter's death.
Paloma had also claimed her human rights had been violated by NHS practitioners, likening it to what the Nazis did during WWII, the inquest was told at Oakwood House in Maidstone, Kent.
In previous written statements - submitted to the family division of the High Court in spring 2024 and read out at the hearing on Monday - she described the alleged violations as akin to experiments carried out at Auschwitz.
Paloma, who grew up in Uckfield, East Sussex, denied even having non-Hodgkin lymphoma, calling it an "absurd fantasy, with no proof".
The Cambridge graduate described the diagnosis as "suspected and unconfirmed", adding that she had a "background in natural healing".
In addition, she feared that if she were to survive chemotherapy it might make her infertile.
"I do not want to undergo such a harsh treatment that could even kill me when there is a possibility this is not cancer", she said.
She described her mother, who was struck off as a nurse in 2021, as "an extremely forceful advocate for natural health" who was often "misquoted".
Paloma had turned to Gerson therapy - a strict organic vegetarian diet involving enemas - on the advice of her mother's ex-fiancee, Dr Patrick Villers, though Cancer Research UK said there was no scientific evidence of it being an effective treatment.
The proceedings, which involve Maidstone and Tunbridge Wells NHS Trust, were on the appropriateness of her care and heard how Paloma had said she was "delighted" with her alternative treatment and "sure" she would "make a full recovery" if left to continue it.
The inquest, led by coroner Catherine Wood, continues.
Additional reporting from PA Media.
Follow BBC Sussex on Facebook, on X, and on Instagram. Send your story ideas to southeasttoday@bbc.co.uk or WhatsApp us on 08081 002250.
'Our sister died of cancer because of our mum's conspiracy theories'
Concern mum 'influenced daughter's chemo refusal'
Related internet links
Kent and Medway Coroner's Service
Solve the daily Crossword
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO
AstraZeneca (AZN) is shifting its focus to the US, calling itself an "American company" on Tuesday as it ramps up manufacturing and proposes price cuts for the US market. CEO Pascal Soriot told reporters Tuesday that the company, which reported its best quarter to date on the same day, "We are a very American company. We are global, but we are certainly very much rooted and present in the US." Tuesday's comment comes as the UK-based and UK-listed company is reportedly considering moving its main stock market listing to New York. In addition, the company recently announced $50 billion in manufacturing commitments in the US — including a brand-new facility in Virginia — and stated its goal of having 50% of its revenue come from the US by 2030. AstraZeneca's top-selling drugs include cancer drug Tagrisso and diabetes drug Farxiga. CFO Aradhana Sarin told Yahoo Finance that the moves are independent of Trump's tariff threats of up to 200% on the pharmaceutical industry. "We have been thinking about our strategic manufacturing — this probably goes back 3 or 4 years," she said. "So, post-COVID, we made a strategic decision because we're such a global company that we needed to have segregated supply chains." "This new facility [in Virginia] that we announced was part of the plan anyway," she added. "But that's separate, it's nothing to do with tariffs. It's actually based on the demand that we see potentially for our new cardiovascular medicine." And there are other reasons why the market is more appealing — including how quickly products reach patients in the US versus other countries. "When new therapies come ... the US market is almost the first to provide access to patients. Physicians ... are really into looking at the data," Sarin said, explaining why the US market is more appealing to pharma than other markets. AstraZeneca is also focused on other strategies that appeal to the US government, including price cuts. It sent a proposal to the US government on price reductions for some of its drugs. The proposal is under review, Soriot said. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Click here for in-depth analysis of the latest health industry news and events impacting stock prices Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Ultra-processed baby foods ‘set children up for lifetime of obesity,' experts warn
Ultra-processed baby foods that 'set children up for a lifetime of obesity' are 'dominating' supermarket shelves, experts have warned. A study by researchers at the University of Leeds found that one in three baby food products filling the aisles are classed as ultra-processed foods (UPF), which have been linked to long-term health damage. Researchers have also warned parents over 'misleading' packaging which promotes natural ingredients in a food product that is industrially produced. The team analysed 600 baby food items from major brands and found that a staggering 87 per cent of baby snacks and 79 per cent of baby cereals are classed as UPFs. This means they were made using industrial techniques, with ingredients not typically found in home cooking. They also found 'troubling trends' in popular snacks marketed at infants, including 'melty' puffed snacks and fruit-based chews and bars. The study's authors are now calling on the government to introduce tougher regulations on UPFs, saying the foods on offer 'bear little resemblance to the kind of food young children should be growing up on'. Dr Diane Threapleton, lead researcher and paediatric nutrition expert at the University of Leeds said: 'We're seeing highly processed snacks, sweets, cereals - even meals dominating the baby aisle. These are often marketed as healthy, organic, or with 'no added sugar' claims, but they contain ingredients and undergo processing that bear little resemblance to the kind of food young children should be growing up on. 'These products are setting up babies to crave ultra-processed, overly sweet foods from the very start. There's a real opportunity now for the Government to show it's serious about raising a healthier generation. The current state of the baby food aisle is unacceptable, and it must no longer be ignored.' Their work is backed by the Obesity Health Alliance (OHA), who said the government needs to act 'urgently' to clamp down on the sale of sugary snacks with 'misleading' labelling. The director of the OHA, Katharine Jenner, said: 'The Government's 10-Year Health Plan talks of a moonshot to end obesity, but we'll never get off the launchpad unless we close the gap in our early years. A healthy life starts from the very beginning and right now, we're feeding our babies and toddlers ultra-processed foods that undermine their development and long-term health. 'The baby food aisle is flooded with sugary, ultra-processed snacks that set children up for a lifetime of poor eating habits, obesity, and tooth decay. With the UK in the grip of an oral health crisis, we urgently need government to limit baby food companies from selling high sugar foods with misleading labelling.' She added: 'These products undermine the best intentions of parents and carers, who want to put their child's health first.'
Yahoo
4 hours ago
- Yahoo
Bread winners? The emerging ingredients in bakery
Much like in the confectionery sector, the bakery industry is facing changing consumer habits – and what can appear to be conflicting demands. Bakery remains a core part of consumer diets around the world but shoppers are becoming increasingly aware of the nutritional profile of products, fuelling demand for healthier options. At other times, however, a desire to indulgence can shape purchasing behaviour. Both trends offer opportunities for bakery companies and the right mix of ingredients can help businesses capture market share. Against that backdrop, how can bakery groups use their product recipes to meet demand? Ai Palette, GlobalData's innovation and consumer insights platform, has identified ingredients it believes offer opportunities for bakers to tap into either the rising interest in healthier products, or can attract consumers seeking 'novel experiences' through unusual flavours, or appeal to demand for 'high quality' ingredients in bakery – and sometimes a mix of two or three of these trends. Ai Palette, like Just Food, is owned by GlobalData. The UK-based research and analytics group analysed Ai Palette's database to identify one 'stand-out ingredient' across six geographic markets – the US, the UK, Germany, the UAE, China and Australia. Each ingredient is classified as having 'high growth' and 'high engagement' based upon consumers interactions with them across social media, retail and restaurant industry sites over recent years. In a new research report, GlobalData argues why the six ingredients – miso, morello cherries, cardamom, fig, durian and purple yam – should be of interest to bakery manufacturers, provides suggestions on ingredient pairings and reviews how brands can use the ingredients in their products. GlobalData says the key market for miso is the US, with morello cherries the principal ingredient of interest in for bakery groups operating in the UK and cardamom for those doing business in Germany. The analysts selected fig as of interest to product developers selling bakery products in the UAE, durian for NPD teams in China and purple yam for research execs in Australia. The engagement score GlobalData gives to an ingredient is based on the number of data points in the month. Growth is then calculated based on the increase of the monthly data points over the last two-year period to provide a two-year CAGR. Miso's moment According to GlobalData, the fermented paste has grown in popularity due to its health benefits and its sweet and spicy taste profile. Estimates suggest there are more than 1,000 types of miso, which is crafted primarily from steamed soybeans, grains like rice or barley, salt and koji. The ingredient is making inroads into the bakery category, with GlobalData's report highlighting the foodservice market in the US. Miso's flavour profile ranges from sweet to salty, with lighter varieties generally being sweeter and darker ones exhibiting a more intense umami taste. The researchers say miso is touted for its potential health benefits, including antioxidant properties and probiotics but nutritionists advise moderation due to the ingredient's high sodium content. Nevertheless, miso's popularity is growing in a range of western markets, from Japan to the UK, the report adds. And, looking ahead, GlobalData suggests miso could be used to boost the functional benefits of stevia, citing PureCircle securing approval for a patent to developing a version of the ingredient especially for bakery products. The company intends to enhance the functional properties of the sugar substitute stevia by incorporating phytoestrogens, derived from sources including miso, into upcoming formulations. Why morello cherries are ripe for bakery innovation Morello cherries, known for their tart flavour, were originally grown in the UK. They are commonly found in syrups, jams and as garnishes but, GlobalData says, the ingredient has increased in popularity among UK bakery manufacturers. Used in products like cheesecakes, cupcakes and panna cotta can elevate taste and also attract consumer interest through vibrant colour contrasts. 'For manufacturers, this versatility is crucial; it allows for innovation and differentiation in a competitive market,' the report reads. 'As consumer preferences shift towards unique and visually appealing desserts, leveraging morello cherries can enhance product offerings and drive sales.' Morello cherries, the researchers say, can help bakery manufacturers tap into demand for quality. GlobalData cites consumer research the company conducted in the second quarter of this year in which it asked: 'What does 'good value for money' mean to you when buying bakery, cereals and morning goods?' Top of the list of answers came 'high quality products/ingredients' at 36%. However, 'low price/cheap' was second at 27%. The scores may cause furrowed brows among NPD teams at bakery manufacturers but GlobalData argues morello cherries can provide an answer. 'Morello cherries can enhance the overall quality of products while remaining cost-effective, making them an appealing option for manufacturers,' the report reads. 'By incorporating morello cherries, producers can meet consumer expectations for both superior quality and reasonable pricing, ultimately fostering customer loyalty and driving sales in a competitive market.' The research suggests the UK is a market where the ingredient is proving popular among bakery manufacturers. GlobalData points to recent new products from Tesco, from foodservice supplier Dawn Foods and from upmarket, Mars-owned chocolate retailer Hotel Chocolat. Yes to purple yam Purple yams, also known as ube, are gaining recognition for their nutritional benefits and culinary versatility. Native to South East Asia, the starchy vegetable boasts a vibrant purple hue, a sweet, nutty flavour and is rich in antioxidants. They are a staple in Filipino cuisine, used in both sweet and savoury dishes and, as health-conscious consumers seek out nutrient-dense foods, purple yams are emerging as a popular choice in bakery. GlobalData's researchers have picked out Australia as a potential market for the ingredient, especially in Australia. The researchers suggest Australian Gen Zers are more likely than older cohorts to have a positive sentiment towards the health properties of purple yams. They cite consumer research from the first quarter of the year in which more than half Australians expressed a 'positive' view towards antioxidants. 'This presents a future opportunity for manufacturers to position purple yams as a nutritious option rich in antioxidants, appealing to health-conscious consumers,' they write. The ingredient is emerging specifically in independent restaurants in Australia (Nimbo's launch of an Ube Toastie in 2024 has led to industry awards) but there is education to be done. More than half of Australians (52%) remain unfamiliar with the ingredient, GlobalData says. . "Bread winners? The emerging ingredients in bakery" was originally created and published by Just Food, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
